Market revenue in 2023 | USD 23.1 million |
Market revenue in 2030 | USD 39.7 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Tandem mass spectrometry |
Fastest growing segment | Tandem Mass Spectrometry |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Tandem mass spectrometry was the largest segment with a revenue share of 24.68% in 2023. Horizon Databook has segmented the South Africa newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study published in South African Medical Journal, permanent hearing impairment is reviewed in over 180,000 babies with about 17 being born each day. To accurately diagnose the presence of this disorder, the public health sector has set up the Early Hearing Detection and Intervention (EHDI) program.
Reason for low implementation of screening was concluded to be due to three factors. These include non inclusion of the screening procedure in maternity birthing package, lack of cost coverage by Medical Aid Scheme, and poor follow-up by the parents. An effort towards eradication of these challenges over the forecast period is expected to make South Africa a lucrative market for the industry.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account